# Sandip Patel

Топ епизоди на подкаста
Актуализирано:

A Closer Look at...Stem Cells and Clinical Trials

Clinical trials turn scientific discoveries into real options for patients and volunteers, advancing care while safeguarding participants. Sheldon Morris, M.D., M.P.H., explains how independent oversight, core ethical principles, and stepwise phases evaluate safety and benefit, and clarifies partic…

A Closer Look at...Stem Cells and Clinical Trials

Clinical trials turn scientific discoveries into real options for patients and volunteers, advancing care while safeguarding participants. Sheldon Morris, M.D., M.P.H., explains how independent oversight, core ethical principles, and stepwise phases evaluate safety and benefit, and clarifies partic…

A Closer Look at...Stem Cells and Clinical Trials

Clinical trials turn scientific discoveries into real options for patients and volunteers, advancing care while safeguarding participants. Sheldon Morris, M.D., M.P.H., explains how independent oversight, core ethical principles, and stepwise phases evaluate safety and benefit, and clarifies partic…

Migraine: what do pharmacists need to know?

Article Supported By Pfizer Financial support was provided from Pfizer Ltd. Pfizer have provided only financial support and have had no input into the development or content of the project and associated materials. In this episode of The PJ Pod, senior editor Alex Clabburn shares insights from a r…

Inside IBM’s Vision for India: AI, Hybrid Cloud, and Building a Future-Ready Workforce

Think Mumbai was electric. India’s AI build-out just moved into a higher gear. I sat down with Sandip Patel, Managing Director, IBM India & South Asia at IBM’s Mumbai office. We unpack what Think Mumbai means for teams building with AI, hybrid cloud, and data at scale. What stood out and why it ma…

iwCART Sessions: CAR-T clinical advances in lung cancer

The International Workshop on CAR-T (iwCAR-T) 2022 featured many updates on the development of CAR T-cell therapies for the treatment of solid tumors. This roundtable discussion on the development of cellular therapies in lung cancer was chaired by Melissa Johnson, MD from the Sarah Canon Research …

What do I need to know about AI? Discussing the Role of AI in Thoracic Oncology

This episode of Lung Cancer Considered examines how artificial intelligence is being incorporated into patient care and what the future holds for this emerging technology. We will be discussing: • Is AI the right move for oncology care? • What is the impact on patient care and our patient expert’s…

Optimizing Novel Therapies and Surgery in Early-Stage NSCLC

Doctors Vamsi Velcheti, Sandip Patel, and Michael Zervos discuss recent updates on the management of early-stage non-small cell lung cancer (NSCLC), including the optimization of neoadjuvant and adjuvant treatment options for patients and the role of surgery in the era of targeted therapy and immun…

LTM Builds a Lightwell Remediation Services Practice Around IBM and Red Hat’s $5B Open-Source Program

LTM, the Larsen & Toubro Group services company that was LTIMindtree until its February rebrand, is building a Lightwell remediation services practice around the $5 billion IBM and Red Hat program for securing open-source software with AI-generated, vendor-validated fixes. IBM’s clearinghouse pr…

S19 Ep12: Order Both IHC and NGS: Defining MET Alterations and Positioning Telisotuzumab Vedotin in Non–Small Cell Lung Cancer

In today’s episode, we spoke with Lyudmila Bazhenova, MD, and Sandip Patel, MD. Dr Bazhenova is a thoracic medical oncologist and co-lead of the lung cancer team at University of California San Diego Moores Cancer Center, and Dr Patel is a professor of medical oncology at UC San Diego. In our exc…